Search for: "Hoffman La-Roche Inc." Results 121 - 131 of 131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Sep 2007, 10:48 am
Hoffman-La Roche, Inc., 917 A.2d 767 (N.J. 2007), reversed another case (relied upon by the Appellate Division), finding it improper to apply New Jersey product liability (not consumer fraud) standards nationwide.While we correctly predicted the result, we were dead wrong about the rationale the supreme court chose to get there. [read post]
12 Sep 2008, 2:33 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Australian Review of National Innovation System released: (IPRoo), (Mallesons Stephen Jaques), (creativecommons.org), (IP Menu News), Senate Committee on the Judiciary approval of Enforcement of Intellectual Property Rights Act 2008 and surrounding debate (Law360), (Public Knowledge), (Ars Technica), (Wired), (Public Knowledge), (Ars Technica),… [read post]
27 Apr 2007, 12:04 pm
By Hal WegnerBefore an overflow hearing room on an internationally available web broadcast, Chairman Howard Berman of the House Judiciary Subcommittee relevant to patents hosted a most informative and candid hearing yesterday afternoon joined by roughly ten of his committee colleagues, including Rep. [read post]
9 May 2007, 1:34 pm
"The Draft continues to use the "carve at the joint" metaphor from In re Rhone-Poulenc Rorer, Inc., 51 F.3d 1293 (7th Cir. 1995) (e.g., §2.03, comment c & Reporters' Notes) to justify widespread issue certification, even though Rhone-Poulenc used that phrase not in support of issue certification, but to caution against bifurcating a trial in a way that would have different juries examining the same issue in violation of the Seventh Amendment. 51 F.3d… [read post]
19 Sep 2008, 6:00 pm
: (IP finance), United States: An open letter for the General Counsel of the PTO on your San Diego presentation next week: (Hal Wegner), United States: Cocoa genome: breaking intellectual property barriers: (Thomson Reuters Scientific), Vietnam: Patentability of second medical use claims in Vietnam is again questionable: (Trung Truc JSC)   Pharma & Biotech - Products Allegra (Fexofenadine) - Canada: Motion for summary judgment of noninfringement dismissed in patent infringement… [read post]